We have cloned the cDN} encodiig human peroxisomal acyl-CoA oxidase, the first enzyme in the peroxisomal 13-oxidation of very long cha in fatty acids. Its nucleotv e sequence was foundl to be h ighly homologous (85' to the rat cDNA countei part.
Introduction
Peroxisomes are subcellular organelles with an important function in cellular metabolic processes including the /-oxidation of very long chain fatty acids (1) and the synthesis of bile acids (2) and ether-phospholipids (3) . The importance of peroxisomes for cellular metabolism is stressed by the discovery of a number of serious inborn errors of peroxisomal metabolism in humans (4) (5) (6) (7) .
Disorders with defective peroxisome assembly such as the Zellweger cerebro-hepato-renal syndrome (7), neonatal adrenoleukodystrophy (4) , and infantile phytanic acid storage disease (5) are characterized by a decreased number or an absence Received for publication 6 July 1993 (6) .
Peroxisomal /-oxidation of fatty acids is catalyzed by three enzymes that are immunologically distinct from the analogous mitochondrial enzymes: (1) acyl-CoA oxidase; (2) a trifunctional enzyme containing enoyl-CoA hydratase, 3-hydroxy-acyl-CoA dehydrogenase, and enoyl-CoA isomerase activities (previously named bifunctional enzyme; 8); and (3) peroxisomal /3-ketothiolase. The peroxisomal /3-oxidation pathway appears to be active toward saturated VLCFA (1) . An Total human liver RNA (10 ptg) was reverse transcribed to cDNA, using a 21 -bp specific primer complementary to the 3' end of the human clones obtained previously, using reverse transcriptase (GIBCO BRL, Gaithersburg, MD) as recommended by the manufacturer. For secondstrand cDNA synthesis and PCR amplification of subsequent fragments (Taq-polymerase, 2.5 U; Perkin-Elmer Cetus Instruments, Norwalk, CT), forward primers derived from the rat cDNA sequence were selected. Sequence analysis of these fragments provided information for reverse transcription and amplification of the next fragment. This procedure of using specific human oligonucleotides as backward primers and specific rat oligonucleotides as forward primers was repeated. To obtain the 5' end of the cDNA, these fragments served as probes for screening a larger human liver cDNA X-gtl 1 library (14) . One single recombinant containing an incomplete insert was selected and used as probe for screening another library (human B cell line cDNA library in pCDM8). A cDNA clone of 2.1 kb encoding the complete protein was obtained.
Primers used. The synthetic oligonucleotides used in PCR sequencing analysis of the human acyl-CoA oxidase cDNA are shown in Table  I . The coordinates (numbering starts at ATG codon) are based on the human (H) (Fig. 1) p/g/ml herring sperm DNA. Filters were washed in 2 x SSPE/0.1% SDS, 1 x SSPE/0.1% SDS, and 0.1 x SSPE/0.1% SDS as recommended by the manufacturer.
For hybridizing the Southern blots, the full length cDNA was digested with the restriction enzyme Dral, giving a 5' fragment (nucleotides 0-264) and a 3' fragment (nucleotides 265-2092), and both fragments were labeled using the Amersham labeling kit and 32P-labeled dCTP. An average of 2.106 cpm/ml was used per blot. Blots were scanned with a phosphorimager.
Results
Isolation of the human acyl-CoA oxidase cDNA. To study the molecular defect in our patients with an acyl-CoA oxidase deficiency, we set out to clone a full-length human acyl-CoA oxidase cDNA. To that end, a X-gtlO human liver cDNA library was screened with a probe representing exon 13 of the rat acylCoA oxidase gene. The two short human clones (±200 bp) obtained had an 84% homology to the rat cDNA sequence.
Further screening of this library failed to give larger clones. Therefore, we amplified reverse-transcribed human liver mRNA using primers based on the rat cDNA sequence. Most of the cDNA sequence was obtained in three amplification steps using primers 1-H13 [3] and 4-R8 [5] , 3-H11 [3] and 6-R6 [5] , and 7-H6 [ 3] and 8-RI [5 ] . This yielded overlapping fragments of 849, 843, and 774 bp, respectively. The 5' end, however, remained elusive.
Screening of a X-gtI 1 human liver cDNA library (containing large inserts) was carried out using PCR fragments as probes and gave an incomplete 1.9-kb insert. Since this insert did not include the 5' end of the cDNA, a third library (a B cell line cDNA library) was screened. The 2.1-kb insert obtained from this last library encoded the complete protein sequence.
The B cell cDNA sequence contained a region of 160 nucleotides (nucleotides 270-429; Fig. 1 ), which was different from the cDNA sequence of the 1.9-kb liver cDNA clone. Further PCR amplification using primers 9-HI [5 ] and 7-H6 [3 ] on liver mRNA gave a 774-bp fragment with either sequences though never both together, whereas amplification of lymphocyte mRNA gave only one type of sequence. The sequence found only in liver mRNA was called type I, and the sequence found in both liver and lymphocytes mRNA was called type II (Fig. 2) .
The nucleotide sequence of the human acyl-CoA oxidase cDNA ( Fig. 1 ) was found to be highly homologous to its rat cDNA counterpart. The homology between the two sequences averaged 85% at the nucleotide level and 89% at the amino acid level (Fig. 3 ) . As in the rat ( 13 ), two species of acyl-CoA oxidase cDNA were found in the liver differing in the region of nucleotides 270-429 (type I and H; Fig. 2 GAG TT GGC ATC COT GAC CCT GAT GAA ATT ATG TGG TTT AAA AAA CTA CAT TTO 0TC AAT TTT GTG GAA CCT Fig. 2 Figure 3 . Comparison between the predicted amino acid sequences of the human and the rat acyl-CoA oxidase type I. The human amino acid sequence is given in single letter code. Amino acid identity between the rat and human sequence is indicated by a dot above the human sequence and mismatches by the corresponding rat amino acid. The numbering indicated is that of the human amino acid sequence. lymphoblastoid cell lines from the siblings with an acyl-CoA oxidase deficiency, their parents, and controls, was digested with restriction enzymes Bgll, EcoRI, and Hindu and probed with the cDNA. A partial deletion of the acyl-CoA oxidase gene was detected in the patients, regardless of the restriction enzyme used. Patients' DNA digested with restriction enzyme EcoRI lacked the 8.0-, 5.5-, and 2.4-kb fragments when probed with the 3' fragment including the type II region (nucleotides 265-2092; Fig. 4 A) . The same blot was reprobed with a 5' fragment from the human clone, homologous to the first two exons of the rat gene (nucleotides 0-264). A 16-kb fragment was now found to be present in patients as well as in controls (Fig. 4  B) . This observation was confirmed by PCR amplification using oligonucleotides 9-Hi [5] and 1 -H2 [3] , both situated at the 5' end of the cDNA, on genomic DNA from patients and controls. A 500-bp fragment was found to be present both in the probands and in the controls. This fragment was sequenced and apparently included an intron at a position equivalent to the rat intron 1.
Although the exact boundaries of the deletion remain to be determined, we conclude that the deletion in the patients spans most of the gene as observed by Southern blot analysis. However, the first two exons were left intact. These results indicate that the acyl-CoA oxidase deficiency in this family is due to a large deletion in the acyl-CoA oxidase gene. Sequence analysis of the human acyl-CoA oxidase cDNA revealed an 85% homology with the rat nucleotidic sequence. Interestingly, we have observed that one codon of the rat exon 14 (nucleotides 1951-1953 ) is absent in the human cDNA sequence. We have also observed the presence of two cDNAs in the liver differing in the region of nucleotides 270-429, a region which corresponds to an alternative usage of rat exon 3 ( 16). The presence of both types of mRNA in the liver but not in lymphocytes may be related to the essential role of liver peroxisomes in 1.-oxidation of VLCFA.
An 89% homology was found between the deduced amino acid sequences of rat and human acyl-CoA oxidase genes. The carboxy termini of the human and rat acyl-CoA oxidase enzyme are highly homologous (88% homology in the last 50 amino acids). Like the rat homologue, the human sequence also contains the carboxy-terminal Ser-Lys-Leu (SKL) (residues 656-660, Fig. 1 ) motif shown to function as a peroxisomal targeting signal in the rat acyl-CoA oxidase in vitro (17) . This sequence has been shown to direct the import of proteins into peroxisomes in many organisms (18) ..
Simultaneous to the sequencing of the human acyl-CoA oxidase cDNA, we analyzed the occurrence of RFLP in the human acyl-CoA oxidase gene. No RFLP were found for 11 enzymes tested. From Southern blotting, the size of the human acyl-CoA oxidase gene was estimated to be -30-40 kb. The rat gene spans 25 kb (16) .
Southern blot analyses in the affected family reveal the presence of a deletion of at least 20 kb in the two patients, corresponding to approximately two-thirds of the acyl-CoA oxidase gene. The 5' boundary of the deletion maps downstream of exon 2; both exons were found to be present by Southern blotting and PCR amplification. However, the extent of the deletion beyond the 3' end of the gene remains unknown. The observed deletion accounts for the absence of the acyl-CoA oxidase protein shown by immunoblotting experiments on liver tissues from one of the patients (11). The detection of 25% residual enzymatic activity in patient's liver, however, is likely due to the activity of trihydroxycoprostanoyl-CoA acid oxidase (19) . The normal plasma values of di-and trihydroxycoprostanoic acids are indirect evidence of the normal activity of the trihydroxycoprostanoyl-CoA oxidase enzyme in the patients.
Very little is known about the molecular basis of peroxisomal diseases, as peroxisome research is a relatively new field. The precise cause of the defects remains unknown in many cases of generalized peroxisomal deficiencies. However, the specific genes involved and the molecular defects are being elucidated gradually and, as expected, include both DNA rearrangements and point mutations.
Disorders with multiple peroxisomal dysfunction (Zellweger syndrome, neonatal adrenoleukodystrophy, and infantile Refsum disease) can be classified in at least eight complementation groups (20), suggesting a multigenic origin of the disease. A microdeletion of the proximal long arm (21 ) and a pericentric inversion of chromosome 7 (22) have been observed in two unrelated patients affected by Zellweger syndrome, a disorder of peroxisome assembly. These findings have led to the tentative assignment of one of the genes responsible for Zellweger syndrome to 7q11. 23 .
Recently, point mutations were found in two peroxisomal membrane proteins in Zellweger syndrome patients. One patient had a point mutation in the 35-kD membrane protein-coding sequence (23) . Two other patients had a splice site or missense mutation in the gene of the 70-kD membrane protein (24) .
A patient suffering from a single enzyme defect in the peroxisomal /3-oxidation did not display a detectable DNA rearrangement of the human peroxisomal 03-ketothiolase gene in genomic DNA (9) . This patient had more serious clinical symptoms than our patients which may be due to the peroxisomal thiolase involvement in the ,/-oxidation of di-and trihydroxycoprostanoic acids as well as of VLCFA. Recently, a rearrangement altering the color pigment genes in a patient with X-linked adrenoleukodystrophy was shown to include two deletions apparently separated by a large inversion on chromosome Xq28 (25) . Further investigation of this region led to the cloning of a gene with significant homology to a peroxisomal 70-kD membrane protein which was partially deleted in 7% of 85 X-linked adrenoleukodystrophy patients (26) . X-linked adrenoleukodystrophy is now thought to be associated with a defect in the transport of the peroxisomal acyl-CoA synthetase, the enzyme responsible for the activation of VLCFA before their /3-oxidation in the peroxisome (27) .
The present study reports the existence of a large deletion in two related patients with a deficiency in the peroxisomal acyl-CoA oxidase. This is the first molecular defect found to be associated with this disease. Additional patients, unrelated to the probands of this study, have been identified by using complementation analysis between cell lines of unknown patients with those of patients with known specific enzymatic defects in the VLCFA /3-oxidation (28) . The available human acyl-CoA oxidase cDNA sequence will allow the detenrination of additional molecular defects resulting in this disease.
